Valuation: Arcoma AB

Market Cap 108M 10.74M 9.58M 8.93M 8.13M 15.3M 1.03B 15.41M 41.97M 528M 40.33M 39.46M 1.7B P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 72.66M 7.24M 6.45M 6.01M 5.47M 10.31M 697M 10.38M 28.27M 356M 27.16M 26.57M 1.14B EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
57.91%
Yield 2024 *
-
Yield 2025 -
1 day+0.80%
1 week+5.01%
Current month+3.86%
1 month-5.75%
3 months-10.24%
6 months-6.68%
Current year+2.72%
1 week 6.9
Extreme 6.9
7.54
1 month 6.56
Extreme 6.56
8.34
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
10.05
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
18.3
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 31/12/2022
Director of Finance/CFO - 14/08/2026
Chief Tech/Sci/R&D Officer - 31/05/2026
Director TitleAgeSince
Director/Board Member 55 31/12/2011
Chairman 54 31/12/2016
Director/Board Member 59 31/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%+5.01%-17.86%+5.45% 10.74M
+3.35%-0.27%+24.56%+35.89% 250B
+3.34%-2.69%+2.89%+2.00% 156B
+3.71%-2.00%-10.14%+40.12% 144B
-0.47%-3.88%-56.43%-17.96% 61.45B
+2.44%+0.46%+13.18%+20.82% 50.28B
-1.08%-3.15%-21.39%-21.55% 46.73B
+2.09%-2.24%+20.93%+55.22% 48.29B
+3.70%+1.25%-4.33%+40.74% 45.89B
+3.51%-0.64%+34.02%+65.46% 43.24B
Average +2.26%-1.59%-1.46%+22.62% 84.52B
Weighted average by Cap. +2.85%-2.77%+4.28%+25.27%

Financials

2024 2025
Net sales 157M 15.61M 13.93M 12.98M 11.81M 22.24M 1.5B 22.4M 61.01M 767M 58.62M 57.35M 2.47B 131M 13.02M 11.62M 10.82M 9.85M 18.55M 1.25B 18.69M 50.89M 640M 48.89M 47.84M 2.06B
Net income 11.18M 1.11M 993K 925K 842K 1.59M 107M 1.6M 4.35M 54.72M 4.18M 4.09M 176M 5.03M 501K 447K 416K 379K 713K 48.24M 719K 1.96M 24.62M 1.88M 1.84M 79.14M
Net Debt -13.32M -1.33M -1.18M -1.1M -1M -1.89M -128M -1.9M -5.18M -65.18M -4.98M -4.87M -210M -35.23M -3.51M -3.13M -2.92M -2.65M -5M -338M -5.03M -13.71M -172M -13.17M -12.88M -554M
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
33
Date Price Change Volume
05/10/26 SEK 7.540 +0.80% 1,526
02/10/26 SEK 7.480 +3.03% 8,700
30/09/26 SEK 7.260 -1.36% 184
29/09/26 SEK 7.360 +2.51% 15

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock